Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?
MeiraGTx Holdings plc MGTX on Thursday announced an asset purchase agreement with Janssen Pharmaceuticals Inc, a Johnson & Johnson JNJ company, for the remaining interests in botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for X-linked retinitis pigmentosa (XLRP). MeiraGTx will monetize…
#johnsonjohnsonjnj #uclbusinessplc #meiragtx #sanofisa #sanofi #centralnervoussystem #glp1 #phase2xerostomia